Perfusion CT in Squamous Cell Carcinoma of the Upper Aerodigestive Tract: Long-Term Predictive Value of Baseline Perfusion CT Measurements

References

1. 1.↵
   1. Pignon JP,
   2. Bourhis J,
   3. Domenge C,
   4. et al

   . Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data—MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet 2000;355:949–55

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Bourhis J,
   2. Calais G,
   3. Lapeyre M,
   4. et al

   . Concomitant radiochemotherapy or accelerated radiotherapy: analysis of two randomized trials of the French Head and Neck Cancer Group (GORTEC). Semin Oncol 2004;31:822–26

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Garden AS,
   2. Harris J,
   3. Trotti A,
   4. et al

   . Long-term results of concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: a phase II trial of the radiation therapy oncology group (RTOG 99–14). Int J Radiat Oncol Biol Phys 2008;71:1351–55

   PubMedWeb of Science
4. 4.↵
   1. Bisdas S,
   2. Baghi M,
   3. Smolarz A,
   4. et al

   . Quantitative measurements of perfusion and permeability of oropharyngeal and oral cavity cancer, recurrent disease, and associated lymph nodes using first-pass contrast-enhanced computed tomography studies. Invest Radiol 2007;42:172–79

   CrossRefPubMed
5. 5.↵
   1. Bisdas S,
   2. Medov L,
   3. Baghi M,
   4. et al

   . A comparison of tumour perfusion assessed by deconvolution-based analysis of dynamic contrast-enhanced CT and MR imaging in patients with squamous cell carcinoma of the upper aerodigestive tract. Eur Radiol 2008;18:843–50

   CrossRefPubMed
6. 6.↵
   1. Gandhi D,
   2. Hoeffner EG,
   3. Carlos RC,
   4. et al

   . Computed tomography perfusion of squamous cell carcinoma of the upper aerodigestive tract: initial results. J Comput Assist Tomogr 2003;27:687–93

   CrossRefPubMed
7. 7.↵
   1. Hermans R,
   2. Lambin P,
   3. Van den Bogaert W,
   4. et al

   . Non-invasive tumour perfusion measurement by dynamic CT: preliminary results. Radiother Oncol 1997;44:159–62

   CrossRefPubMed
8. 8.↵
   1. Rumboldt Z,
   2. Al-Okaili R,
   3. Deveikis JP

   . Perfusion CT for head and neck tumors: pilot study. AJNR Am J Neuroradiol 2005;26:1178–85

   Abstract/FREE Full Text
9. 9.↵
   1. Gandhi D,
   2. Chepeha DB,
   3. Miller T,
   4. et al

   . Correlation between initial and early follow-up CT perfusion parameters with endoscopic tumor response in patients with advanced squamous cell carcinomas of the oropharynx treated with organ-preservation therapy. AJNR Am J Neuroradiol 2006;27:101–06

   Abstract/FREE Full Text
10. 10.↵
    1. Zima A,
    2. Carlos R,
    3. Gandhi D,
    4. et al

    . Can pretreatment CT perfusion predict response of advanced squamous cell carcinoma of the upper aerodigestive tract treated with induction chemotherapy? AJNR Am J Neuroradiol 2007;28:328–34

    Abstract/FREE Full Text
11. 11.↵
    1. Hermans R,
    2. Meijerink M,
    3. Van den Bogaert W,
    4. et al

    . Tumor perfusion rate determined noninvasively by dynamic computed tomography predicts outcome in head-and-neck cancer after radiotherapy. Int J Radiat Oncol Biol Phys 2003;57:1351–56

    CrossRefPubMedWeb of Science
12. 12.↵
    1. Hoskin PJ,
    2. Saunders MI,
    3. Goodchild K,
    4. et al

    . Dynamic contrast enhanced magnetic resonance scanning as a predictor of response to accelerated radiotherapy for advanced head and neck cancer. Br J Radiol 1999;72:1093–98

    Abstract
13. 13.↵
    1. Bisdas S,
    2. Nguyen SA,
    3. Anand SK,
    4. et al

    . Outcome prediction after surgery and chemoradiation of squamous cell carcinoma in the oral cavity, oropharynx, and hypopharynx: use of baseline perfusion CT microcirculatory parameters vs. tumor volume. Int J Radiat Oncol Biol Phys 2009;73:1313–18. Epub 2008 Oct 27

    PubMed
14. 14.↵
    1. Bisdas S,
    2. Surlan-Popovic K,
    3. Didanovic V,
    4. et al

    . Functional CT of squamous cell carcinoma in the head and neck: repeatability of tumor and muscle quantitative measurements—inter- and intra-observer agreement. Eur Radiol 2008;18:2241–50

    CrossRefPubMed
15. 15.↵
    1. Cohen EE,
    2. Haraf DJ,
    3. List MA,
    4. et al

    . High survival and organ function rates after primary chemoradiotherapy for intermediate-stage squamous cell carcinoma of the head and neck treated in a multicenter phase II trial. J Clin Oncol 2006;24:3438–44

    Abstract/FREE Full Text
16. 16.↵
    1. Calvin DP,
    2. Hammond ME,
    3. Pajak TF,
    4. et al

    . Microvessel density >or=60 does not predict for outcome after radiation treatment for locally advanced head and neck squamous cell carcinoma: results of a correlative study from the Radiation Therapy Oncology Group (RTOG) 90–03 Trial. Am J Clin Oncol 2007;30:406–19

    CrossRefPubMed
17. 17.↵
    1. St Lawrence KS,
    2. Lee TY

    . An adiabatic approximation to the tissue homogeneity model for water exchange in the brain. II. Experimental validation. J Cereb Blood Flow Metab 1998;18:1378–85

    CrossRefPubMed
18. 18.↵
    1. St Lawrence KS,
    2. Lee TY

    . An adiabatic approximation to the tissue homogeneity model for water exchange in the brain. I. Theoretical derivation. J Cereb Blood Flow Metab 1998;18:1365–77

    CrossRefPubMed
19. 19.↵
    1. Bisdas S,
    2. Foo CZ,
    3. Thng CH,
    4. et al

    . Optimization of perfusion CT protocol for imaging of extracranial head and neck tumors. J Digit Imaging 2008 5 3. [Epub ahead of print]
20. 20.↵
    1. Devries AF,
    2. Griebel J,
    3. Kremser C,
    4. et al

    . Tumor microcirculation evaluated by dynamic magnetic resonance imaging predicts therapy outcome for primary rectal carcinoma. Cancer Res 2001;61:2513–16

    Abstract/FREE Full Text
21. 21.↵
    1. Xuan JW,
    2. Bygrave M,
    3. Jiang H,
    4. et al

    . Functional neoangiogenesis imaging of genetically engineered mouse prostate cancer using three-dimensional power Doppler ultrasound. Cancer Res 2007;67:2830–39

    Abstract/FREE Full Text
22. 22.↵
    1. Axelson H,
    2. Fredlund E,
    3. Ovenberger M,
    4. et al

    . Hypoxia-induced dedifferentiation of tumor cells: a mechanism behind heterogeneity and aggressiveness of solid tumors. Semin Cell Dev Biol 2005;16:554–63

    CrossRefPubMedWeb of Science
23. 23.↵
    1. Vaupel P

    . Oxygen transport in tumors: characteristics and clinical implications. Adv Exp Med Biol 1996;388:341–51

    PubMed
24. 24.↵
    1. Keski-Santti H,
    2. Atula T,
    3. Tikka J,
    4. et al

    . Predictive value of histopathologic parameters in early squamous cell carcinoma of oral tongue. Oral Oncol 2007;43:1007–13

    CrossRefPubMed
25. 25.↵
    1. Hermans R,
    2. Op de beeck K,
    3. Van den Bogaert W,
    4. et al

    . The relation of CT-determined tumor parameters and local and regional outcome of tonsillar cancer after definitive radiation treatment. Int J Radiat Oncol Biol Phys 2001;50:37–45

    PubMed
26. 26.↵
    1. Lam W,
    2. Bussom S,
    3. Cheng YC

    . Effect of hypoxia on the expression of phosphoglycerate kinase and antitumor activity of troxacitabine and gemcitabine in non-small cell lung carcinoma. Mol Cancer Ther 2009;8:415–23. Epub 2009 Feb 10

    Abstract/FREE Full Text
27. 27.↵
    1. Mayr NA,
    2. Wang JZ,
    3. Zhang D,
    4. et al

    . Synergistic effects of hemoglobin and tumor perfusion on tumor control and survival in cervical cancer. Int J Radiat Oncol Biol Phys 2009;74:1513–21. Epub 2009 Mar 13

    PubMed
28. 28.↵
    1. Titz B,
    2. Jeraj R

    . An imaging-based tumour growth and treatment response model: investigating the effect of tumour oxygenation on radiation therapy response. Phys Med Biol 2008;53:4471–88. Epub 2008 Aug 1

    CrossRefPubMedWeb of Science
29. 29.↵
    1. Silva P,
    2. Slevin NJ,
    3. Sloan P,
    4. et al

    . Prognostic significance of tumor hypoxia inducible factor-1alpha expression for outcome after radiotherapy in oropharyngeal cancer. Int J Radiat Oncol Biol Phys 2008;72:1551–59

    PubMed
30. 30.↵
    1. Jeremic B,
    2. Milicic B

    . Pretreatment prognostic factors of survival in patients with locally advanced nonmetastatic squamous cell carcinoma of the head and neck treated with radiation therapy with or without concurrent chemotherapy. Am J Clin Oncol 2009 3 20. [Epub ahead of print]
31. 31.↵
    1. Pedruzzi PA,
    2. Kowalski LP,
    3. Nishimoto IN,
    4. et al

    . Analysis of prognostic factors in patients with oropharyngeal squamous cell carcinoma treated with radiotherapy alone or in combination with systemic chemotherapy. Arch Otolaryngol Head Neck Surg 2008;134:1196–204

    CrossRefPubMed